New generations of quinolones: with particular attention to levofloxacin.
Ambrose
P G
PG
Hartford Hospital, University of Connecticut, School of Pharmacy, Storrs, USA.
Owens
R C
RC
Quintiliani
R
R
Nightingale
C H
CH
D000890:Anti-Infective Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D017714:Community-Acquired Infections / Q000188:drug therapy; D024841:Fluoroquinolones; D006801:Humans; D064704:Levofloxacin; D015242:Ofloxacin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D011014:Pneumonia / Q000188:drug therapy; D015363:Quinolones / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D015363:Quinolones; D064704:Levofloxacin; D015242:Ofloxacin; C061363:sparfloxacin